SAC Capital Advisors’s Medifast MED Stock Holding History

SAC Capital Advisors’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-10,301	Closed	-$300K	–	614
2014 Q1	$300K	Buy	+10,301	New	+$276K	﹤0.01%	1412
2013 Q3	–	Sell	-19,173	Closed	-$494K	–	1870
2013 Q2	$494K	Buy	+19,173	New	+$504K	﹤0.01%	1105

Other funds holding MED

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

CCM

Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

GGPE

Golden Gate Private Equity San Francisco, California $241M AUM 13.37% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

SAC Capital Advisors's MED Position: Q2 2014 in Review

SAC Capital Advisors sold out of Medifast (MED) in Q2 2014, closing a stake of 10,301 shares — an estimated $300K sold.

SAC Capital Advisors first reported a position in MED in Q2 2013 and held it in 2 quarters. The position peaked at $494K in Q2 2013. 132 funds tracked by Wall St. Rank hold MED as of Q2 2014.

SAC Capital Advisors reported no remaining Medifast position as of Q2 2014 after selling out during the quarter.
SAC Capital Advisors sold 10,301 Medifast shares in Q2 2014, an estimated $300K.
SAC Capital Advisors first reported a position in Medifast in Q2 2013 and held it in 2 quarters.
SAC Capital Advisors's Medifast position peaked at $494K in Q2 2013.
132 funds tracked by Wall St. Rank held Medifast as of Q2 2014.

Based on SAC Capital Advisors's 13F filing for Q2 2014.